Search Results - "Audicio, Paola F."

  • Showing 1 - 4 results of 4
Refine Results
  1. 1

    [ 177Lu]DOTA-anti-CD20: Labeling and pre-clinical studies by Audicio, Paola F., Castellano, Gustavo, Tassano, Marcos R., Rezzano, Maria E., Fernandez, Marcelo, Riva, Eloisa, Robles, Ana, Cabral, Pablo, Balter, Henia, Oliver, Patricia

    Published in Applied radiation and isotopes (01-07-2011)
    “…Anti-CD20 (Rituximab ®), a specific chimeric monoclonal antibody used in CD20-positive Non-Hodgkin's Lymphoma, was conjugated to a bifunctional quelate (DOTA)…”
    Get full text
    Journal Article
  2. 2

    Development of 99mTc(CO)3-dendrimer-FITC for cancer imaging by Tassano, Marcos R., Audicio, Paola F., Gambini, Juan P., Fernandez, Marcelo, Damian, Juan P., Moreno, Maria, Chabalgoity, Jose A., Alonso, Omar, Benech, Juan C., Cabral, Pablo

    Published in Bioorganic & medicinal chemistry letters (15-09-2011)
    “…Scintigraphy image of normal (a) and melanoma-bearing mice (b) injected with 99mTc(CO)3-dendrimer-FITC, 1h post-injection. (a) White and yellow arrows point…”
    Get full text
    Journal Article
  3. 3

    Development of super(99mTc(CO)) sub(3)-dendrimer-FITC for cancer imaging by Tassano, Marcos R, Audicio, Paola F, Gambini, Juan P, Fernandez, Marcelo, Damian, Juan P, Moreno, Maria, Chabalgoity, Jose A, Alonso, Omar, Benech, Juan C, Cabral, Pablo

    Published in Bioorganic & medicinal chemistry letters (15-09-2011)
    “…Study of fluorophore and technetium labeling of poly(amido)-amine (PAMAM) generation 4 (G4) dendrimer and its evaluation as potential molecular imaging agent…”
    Get full text
    Journal Article
  4. 4

    [[super]177Lu]DOTA-anti-CD20: Labeling and pre-clinical studies by Audicio, Paola F, Castellano, Gustavo, Tassano, Marcos R, Rezzano, Maria E, Fernandez, Marcelo, Riva, Eloisa, Robles, Ana, Cabral, Pablo, Balter, Henia, Oliver, Patricia

    Published in Applied radiation and isotopes (01-07-2011)
    “…Anti-CD20 (Rituximab[super][registered]), a specific chimeric monoclonal antibody used in CD20-positive Non-Hodgkin's Lymphoma, was conjugated to a…”
    Get full text
    Journal Article